The Identification of Indacaterol as an Ultralong-Acting Inhaled β2-Adrenoceptor Agonist-Reference-Cited by-同舟云学术

The Identification of Indacaterol as an Ultralong-Acting Inhaled β2-Adrenoceptor Agonist

Published:2010-04-19 Issue:9 Volume:53 Page:3675-3684
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Baur François¹,Beattie David¹,Beer David¹,Bentley David¹,Bradley Michelle¹,Bruce Ian¹,Charlton Steven J.¹,Cuenoud Bernard¹,Ernst Roland¹,Fairhurst Robin A.¹,Faller Bernard²,Farr David¹,Keller Thomas¹,Fozard John R.¹,Fullerton Joe¹,Garman Sheila¹,Hatto Julia¹,Hayden Claire¹,He Handan³,Howes Colin¹,Janus Diana¹,Jiang Zhengjin¹,Lewis Christine¹,Loeuillet-Ritzler Frederique²,Moser Heinz¹,Reilly John¹,Steward Alan¹,Sykes David¹,Tedaldi Lauren¹,Trifilieff Alexandre¹,Tweed Morris¹,Watson Simon¹,Wissler Elke¹,Wyss Daniel¹

Affiliation:

1. Respiratory Diseases Area, Novartis Institutes for Biomedical Research, Wimblehurst Road, Horsham, West Sussex RH12 5AB, U.K. and Lichtstrasse, CH-4056 Basel, Switzerland

2. Metabolism and Pharmacokinetics, Novartis Institutes for Biomedical Research, Novartis Campus, CH-4056 Basel, Switzerland

3. DMPK-Translational Science, Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, New Jersey

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm100068m

Reference49 articles.

1. Global strategy for asthma management and prevention: GINA executive summary

2. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

3. β-Adrenoceptor agonists and asthma—100 years of development